TrialMedical oncology (Northwood, London, England)2022

Predictors of the development of nab-paclitaxel-induced peripheral neuropathy in breast cancer patients: post hoc analysis of a prospective, phase II, self-controlled clinical trial.

Yuko Kanbayashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.